Does REMDESIVIR Cause Diffuse alveolar damage? 15 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Diffuse alveolar damage have been filed in association with REMDESIVIR (Veklury). This represents 0.1% of all adverse event reports for REMDESIVIR.
15
Reports of Diffuse alveolar damage with REMDESIVIR
0.1%
of all REMDESIVIR reports
14
Deaths
1
Hospitalizations
How Dangerous Is Diffuse alveolar damage From REMDESIVIR?
Of the 15 reports, 14 (93.3%) resulted in death, 1 (6.7%) required hospitalization, and 1 (6.7%) were considered life-threatening.
Is Diffuse alveolar damage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REMDESIVIR. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does REMDESIVIR Cause?
Off label use (1,092)
Alanine aminotransferase increased (1,047)
Death (808)
Aspartate aminotransferase increased (713)
Bradycardia (652)
Acute kidney injury (605)
Covid-19 (570)
Drug ineffective (497)
Liver function test increased (447)
Respiratory failure (394)
What Other Drugs Cause Diffuse alveolar damage?
METHYLPREDNISOLONE (135)
CYCLOPHOSPHAMIDE (125)
PREDNISONE (122)
METHOTREXATE (112)
DEXAMETHASONE (84)
VINCRISTINE (78)
CYTARABINE (76)
DAUNORUBICIN (75)
ETOPOSIDE (73)
LEUCOVORIN (73)
Which REMDESIVIR Alternatives Have Lower Diffuse alveolar damage Risk?
REMDESIVIR vs REMERON
REMDESIVIR vs REMICADE
REMDESIVIR vs REMIFENTANIL
REMDESIVIR vs REMIMAZOLAM
REMDESIVIR vs REMODULIN